Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Investigating the role of biofilm formation in Crohn’s Disease-associated Escherichia coli in evading phagocytosis
EF 2023-24
Résumé
Crohn’s Disease (CD) is an idiopathic inflammatory bowel disease. Adherent-invasive Escherichia coli (AIEC) are frequently isolated from CD patients and form biofilms, which are aggregates of bacteria embedded in a self-produced matrix of macromolecules protective against environmental stresses and antibiotics. Biofilm formation is facilitated by the Type IV secretion system (T4SS), a protein nanomachinery that primarily mediates bacterial crosstalk through the secretion of proteins and DNA. More importantly, we found that the T4SS promotes the persistence of AIEC in the gut. We previously determined that effective biofilm formation via T4SS confers protection for AIEC from macrophage-mediated phagocytosis through an in vitro infection model. However, interactions between AIEC and macrophages in vivo are currently unclear; thus, we aim to elucidate whether biofilms are protective in a mice model and the impact of bacterial aggregates on the inflammatory profile of the gut. This will be performed by treating C57BL/6J mice with dextran sodium-sulfate to mimic the CD inflamed gut environment, then infecting our model with a biofilm-proficient or deficient AIEC strain. Immunofluorescence and histology will be employed to visualize gut tissues, while RT-qPCR and ELISAs will quantify differences in levels of inflammatory markers. We expect to see variations in the inflammatory profile of the gut environment in response to these two strains. This project will provide key insight into the role of AIEC in CD with implications for novel therapeutics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506555
Name
Wong Jonas D
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of biofilm formation in Crohn’s Disease-associated Escherichia coli in evading phagocytosis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adherent-Invasive Escherichia Coli; Bacterial Pathogenesis; Biofilms; Crohn'S Disease; Gut Inflammation; Immunology; Macrophage Biology; Microbiology; Phagocytosis; Type Iv Secretion System
Abstract
Crohn’s Disease (CD) is an idiopathic inflammatory bowel disease. Adherent-invasive Escherichia coli (AIEC) are frequently isolated from CD patients and form biofilms, which are aggregates of bacteria embedded in a self-produced matrix of macromolecules protective against environmental stresses and antibiotics. Biofilm formation is facilitated by the Type IV secretion system (T4SS), a protein nanomachinery that primarily mediates bacterial crosstalk through the secretion of proteins and DNA. More importantly, we found that the T4SS promotes the persistence of AIEC in the gut. We previously determined that effective biofilm formation via T4SS confers protection for AIEC from macrophage-mediated phagocytosis through an in vitro infection model. However, interactions between AIEC and macrophages in vivo are currently unclear; thus, we aim to elucidate whether biofilms are protective in a mice model and the impact of bacterial aggregates on the inflammatory profile of the gut. This will be performed by treating C57BL/6J mice with dextran sodium-sulfate to mimic the CD inflamed gut environment, then infecting our model with a biofilm-proficient or deficient AIEC strain. Immunofluorescence and histology will be employed to visualize gut tissues, while RT-qPCR and ELISAs will quantify differences in levels of inflammatory markers. We expect to see variations in the inflammatory profile of the gut environment in response to these two strains. This project will provide key insight into the role of AIEC in CD with implications for novel therapeutics.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wong, Jonas D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~